Draftfcb Healthcare inks deal with global indie agency network

Share this article:
Dana Maiman
Dana Maiman

Draftfcb Healthcare is filling out its global footprint through an alliance with Argon Network, a coalition of 22 indie agencies in Europe, Asia, the Middle East and South America.

Draftfcb Healthcare CEO and president Dana Maiman said the move represents a deepening of the Interpublic Group company's ties to the London-based indie network, which will henceforth be called the Draftfcb Healthcare Worldwide Affiliates Network.  

“We had started to work with them a little on various opportunities and then we said to ourselves, ‘Why not make this exclusive?' They're everywhere, and it's everything from advertising to PR to market research and medical communications, so immediately it gave us a pretty large footprint and options even within markets.”

Maiman said the company, which already boasts seven or eight offices outside of the US, including strong presences in India and South Africa, might ultimately be open to buying some of the Argon shops outright, and that they will be pursuing acquisitions in the meantime.

“We want to strengthen everything, and this gives us an opportunity to go shopping,” she said. “This is more than filling gaps. This is about really finding the right partners.”

The company acquired Tarrytown, NY-based drug marketing shop Hudson Global in September.

The deal comes as Maiman relinquishes the reins at Draftfcb New York, the flagship office of the healthcare network's mainline agency sibling. Maiman had taken on the role of president of Draftfcb New York in 2010 following a period of tumult in the shop's leadership. During her tenure as president, the agency has landed some big non-pharma accounts, including the FDA's anti-tobacco campaigns and work from Fidelity Investments, the US Census, SeaWorld, Busch Gardens and Amtrak while retaining its Jamaica Tourism Board brief.  

She'll now be able to focus exclusively on building out the healthcare business, which is rooted in the network's three New York agencies—NeON, Area 23 and Draftfcb Healthcare—not to mention two med ed companies and a managed markets business. Draftfcb recently took over handling of pharma DTC from Draftfcb New York.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...